Nuvalent to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,James Porter ,Alexandra Balcom ,Nasdaq ,Nuvalent Inc ,Chief Executive Officer ,Chief Financial Officer ,Guggenheim Healthcare Talks ,Annual Biotechnology Conference ,Nuvalent ,Nc ,